Cortisol Explained

Cortisol is a steroid hormone in the glucocorticoid class of hormones and a stress hormone. When used as medication, it is known as hydrocortisone.

It is produced in many animals, mainly by the zona fasciculata of the adrenal cortex in an adrenal gland.[1] In other tissues, it is produced in lower quantities.[2] By a diurnal cycle, cortisol is released and increases in response to stress and a low blood-glucose concentration.[1] It functions to increase blood sugar through gluconeogenesis, suppress the immune system, and aid in the metabolism of calories.[3] It also decreases bone formation.[4] These stated functions are carried out by cortisol binding to glucocorticoid or mineralocorticoid receptors inside a cell, which then bind to DNA to affect gene expression.[1] [5]

Health effects

Metabolic response

Metabolism of glucose

Cortisol plays a crucial role in regulating glucose metabolism and promotes gluconeogenesis (glucose synthesis) and glycogenesis (glycogen synthesis) in the liver and glycogenolysis (breakdown of glycogen) in skeletal muscle.[1] It also increases blood glucose levels by reducing glucose uptake in muscle and adipose tissue, decreasing protein synthesis, and increasing the breakdown of fats into fatty acids (lipolysis). All of these metabolic steps have the net effect of increasing blood glucose levels, which fuel the brain and other tissues during the fight-or-flight response. Cortisol is also responsible for releasing amino acids from muscle, providing a substrate for gluconeogenesis.[1] Its impact is complex and diverse.[6]

In general, cortisol stimulates gluconeogenesis (the synthesis of 'new' glucose from non-carbohydrate sources, which occurs mainly in the liver, but also in the kidneys and small intestine under certain circumstances). The net effect is an increase in the concentration of glucose in the blood, further complemented by a decrease in the sensitivity of peripheral tissue to insulin, thus preventing this tissue from taking the glucose from the blood. Cortisol has a permissive effect on the actions of hormones that increase glucose production, such as glucagon and adrenaline.[7]

Cortisol also plays an important, but indirect, role in liver and muscle glycogenolysis (the breaking down of glycogen to glucose-1-phosphate and glucose) which occurs as a result of the action of glucagon and adrenaline. Additionally, cortisol facilitates the activation of glycogen phosphorylase, which is necessary for adrenaline to have an effect on glycogenolysis.[8]

It is paradoxical that cortisol promotes not only gluconeogenesis (biosynthesis of glucose molecules) in the liver, but also glycogenesis (polymerization of glucose molecules into glycogen): cortisol is thus better thought of as stimulating glucose/glycogen turnover in the liver.[9] This is in contrast to cortisol's effect in the skeletal muscle where glycogenolysis (breakdown of glycogen into glucose molecules) is promoted indirectly through catecholamines.[10] In this way, cortisol and catecholamines work synergistically to promote the breakdown of muscle glycogen into glucose for use in the muscle tissue. [11]

Metabolism of proteins and lipids

Elevated levels of cortisol, if prolonged, can lead to proteolysis (breakdown of proteins) and muscle wasting.[12] The reason for proteolysis is to provide the relevant tissue with a feedstock for gluconeogenesis; see glucogenic amino acids.[7] The effects of cortisol on lipid metabolism are more complicated since lipogenesis is observed in patients with chronic, raised circulating glucocorticoid (i.e. cortisol) levels,[7] although an acute increase in circulating cortisol promotes lipolysis.[13] The usual explanation to account for this apparent discrepancy is that the raised blood glucose concentration (through the action of cortisol) will stimulate insulin release. Insulin stimulates lipogenesis, so this is an indirect consequence of the raised cortisol concentration in the blood but it will only occur over a longer time scale.

Immune response

Cortisol prevents the release of substances in the body that cause inflammation. It is used to treat conditions resulting from overactivity of the B-cell-mediated antibody response. Examples include inflammatory and rheumatoid diseases, as well as allergies. Low-dose topical hydrocortisone, available as a nonprescription medicine in some countries, is used to treat skin problems such as rashes and eczema.

Cortisol inhibits production of interleukin 12 (IL-12), interferon gamma (IFN-gamma), IFN-alpha, and tumor necrosis factor alpha (TNF-alpha) by antigen-presenting cells (APCs) and T helper cells (Th1 cells), but upregulates interleukin 4, interleukin 10, and interleukin 13 by Th2 cells. This results in a shift toward a Th2 immune response rather than general immunosuppression. The activation of the stress system (and resulting increase in cortisol and Th2 shift) seen during an infection is believed to be a protective mechanism which prevents an over-activation of the inflammatory response.[14]

Cortisol can weaken the activity of the immune system. It prevents proliferation of T-cells by rendering the interleukin-2 producer T-cells unresponsive to interleukin-1, and unable to produce the T-cell growth factor IL-2. Cortisol downregulates the expression of the IL2 receptor IL-2R on the surface of the helper T-cell which is necessary to induce a Th1 'cellular' immune response, thus favoring a shift towards Th2 dominance and the release of the cytokines listed above which results in Th2 dominance and favors the 'humoral' B-cell mediated antibody immune response.[15]

Cortisol also has a negative-feedback effect on IL-1.[16] The way this negative feedback works is that an immune stressor causes peripheral immune cells to release IL-1 and other cytokines such as IL-6 and TNF-alpha. These cytokines stimulate the hypothalamus, causing it to release corticotropin-releasing hormone (CRH). CRH in turn stimulates the production of adrenocorticotropic hormone (ACTH) among other things in the adrenal gland, which (among other things) increases production of cortisol. Cortisol then closes the loop as it inhibits TNF-alpha production in immune cells and makes them less responsive to IL-1.[17]

Through this system, as long as an immune stressor is small, the response will be regulated to the correct level. Like a thermostat controlling a heater, the hypothalamus uses cortisol to turn off the heat once the production of cortisol matches the stress induced on the immune system. But in a severe infection or in a situation where the immune system is overly sensitized to an antigen (such as in allergic reactions) or there is a massive flood of antigens (as can happen with endotoxic bacteria) the correct set point might never be reached. Also because of downregulation of Th1 immunity by cortisol and other signaling molecules, certain types of infection, (notably Mycobacterium tuberculosis) can trick the body into getting locked in the wrong mode of attack, using an antibody-mediated humoral response when a cellular response is needed.

Lymphocytes include the B-cell lymphocytes that are the antibody-producing cells of the body, and are thus the main agents of humoral immunity. A larger number of lymphocytes in the lymph nodes, bone marrow, and skin means the body is increasing its humoral immune response. B-cell lymphocytes release antibodies into the bloodstream. These antibodies lower infection through three main pathways: neutralization, opsonization, and complement activation. Antibodies neutralize pathogens by binding to surface adhering proteins, keeping pathogens from binding to host cells. In opsonization, antibodies bind to the pathogen and create a target for phagocytic immune cells to find and latch onto, allowing them to destroy the pathogen more easily. Finally antibodies can also activate complement molecules which can combine in various ways to promote opsonization or even act directly to lyse a bacteria. There are many different kinds of antibody and their production is highly complex, involving several types of lymphocyte, but in general lymphocytes and other antibody regulating and producing cells will migrate to the lymph nodes to aid in the release of these antibodies into the bloodstream.[18]

Rapid administration of corticosterone (the endogenous type I and type II receptor agonist) or RU28362 (a specific type II receptor agonist) to adrenalectomized animals induced changes in leukocyte distribution.

On the other side of things, there are natural killer cells; these cells have the ability to take down larger in size threats like bacteria, parasites, and tumor cells. A separate study[19] found that cortisol effectively disarmed natural killer cells, downregulating the expression of their natural cytotoxicity receptors. Interestingly, prolactin has the opposite effect. It increases the expression of cytotoxicity receptors on natural killer cells, increasing their firepower.

Cortisol stimulates many copper enzymes (often to 50% of their total potential), including lysyl oxidase, an enzyme that cross-links collagen and elastin. Especially valuable for immune response is cortisol's stimulation of the superoxide dismutase,[20] since this copper enzyme is almost certainly used by the body to permit superoxides to poison bacteria.

Some viruses, such as influenza and SARS-CoV-1 and SARS-CoV-2, are known to suppress the secretion of stress hormones to avoid the organism's immune response, thus avoiding the immune protection of the organism. These viruses suppress cortisol by producing a protein that mimics the human ACTH hormone but is incomplete and does not have hormonal activity. ACTH is a hormone that stimulates the adrenal gland to produce cortisol and other steroid hormones. However, the organism makes antibodies against this viral protein, and those antibodies also kill the human ACTH hormone, which leads to the suppression of adrenal gland function. Such adrenal suppression is a way for a virus to evade immune detection and elimination.[21] [22] [23] This viral strategy can have severe consequences for the host (human that is infected by the virus), as cortisol is essential for regulating various physiological processes, such as metabolism, blood pressure, inflammation, and immune response. A lack of cortisol can result in a condition called adrenal insufficiency, which can cause symptoms such as fatigue, weight loss, low blood pressure, nausea, vomiting, and abdominal pain. Adrenal insufficiency can also impair the ability of the host to cope with stress and infections, as cortisol helps to mobilize energy sources, increase heart rate, and downregulate non-essential metabolic processes during stress. Therefore, by suppressing cortisol production, some viruses can escape the immune system and weaken the host's overall health and resilience.[24] [22]

Other effects

Metabolism

Glucose

Cortisol counteracts insulin, contributes to hyperglycemia by stimulating gluconeogenesis and inhibits the peripheral use of glucose (insulin resistance)[25] by decreasing the translocation of glucose transporters (especially GLUT4) to the cell membrane.[1] [26] Cortisol also increases glycogen synthesis (glycogenesis) in the liver, storing glucose in easily accessible form.[27]

Bone and collagen

Cortisol reduces bone formation,[4] favoring long-term development of osteoporosis (progressive bone disease). The mechanism behind this is two-fold: cortisol stimulates the production of RANKL by osteoblasts which stimulates, through binding to RANK receptors, the activity of osteoclasts – cells responsible for calcium resorption from bone – and also inhibits the production of osteoprotegerin (OPG) which acts as a decoy receptor and captures some RANKL before it can activate the osteoclasts through RANK. In other words, when RANKL binds to OPG, no response occurs as opposed to the binding to RANK which leads to the activation of osteoclasts.

It transports potassium out of cells in exchange for an equal number of sodium ions (see above). This can trigger the hyperkalemia of metabolic shock from surgery. Cortisol also reduces calcium absorption in the intestine.[28] Cortisol down-regulates the synthesis of collagen.[29]

Amino acid

Cortisol raises the free amino acids in the serum by inhibiting collagen formation, decreasing amino acid uptake by muscle, and inhibiting protein synthesis.[30] Cortisol (as opticortinol) may inversely inhibit IgA precursor cells in the intestines of calves.[31] Cortisol also inhibits IgA in serum, as it does IgM; however, it is not shown to inhibit IgE.[32]

Electrolyte balance

Cortisol increases glomerular filtration rate,[33] and renal plasma flow from the kidneys thus increasing phosphate excretion,[34] [35] as well as increasing sodium and water retention and potassium excretion by acting on mineralocorticoid receptors. It also increases sodium and water absorption and potassium excretion in the intestines.[36]

Sodium

Cortisol promotes sodium absorption through the small intestine of mammals.[37] Sodium depletion, however, does not affect cortisol levels[38] so cortisol cannot be used to regulate serum sodium. Cortisol's original purpose may have been sodium transport. This hypothesis is supported by the fact that freshwater fish use cortisol to stimulate sodium inward, while saltwater fish have a cortisol-based system for expelling excess sodium.[39]

Potassium

A sodium load augments the intense potassium excretion by cortisol. Corticosterone is comparable to cortisol in this case.[40] For potassium to move out of the cell, cortisol moves an equal number of sodium ions into the cell.[41] This should make pH regulation much easier (unlike the normal potassium-deficiency situation, in which two sodium ions move in for each three potassium ions that move out—closer to the deoxycorticosterone effect).

Stomach and kidneys

Cortisol stimulates gastric-acid secretion.[42] Cortisol's only direct effect on the hydrogen-ion excretion of the kidneys is to stimulate the excretion of ammonium ions by deactivating the renal glutaminase enzyme.[43]

Memory

Cortisol works with adrenaline (epinephrine) to create memories of short-term emotional events; this is the proposed mechanism for storage of flash bulb memories, and may originate as a means to remember what to avoid in the future.[44] However, long-term exposure to cortisol damages cells in the hippocampus;[45] this damage results in impaired learning.

Diurnal cycles

Diurnal cycles of cortisol levels are found in humans.[46]

Stress

Sustained stress can lead to high levels of circulating cortisol (regarded as one of the more important of the several "stress hormones").[47]

Effects during pregnancy

During human pregnancy, increased fetal production of cortisol between weeks 30 and 32 initiates production of fetal lung pulmonary surfactant to promote maturation of the lungs. In fetal lambs, glucocorticoids (principally cortisol) increase after about day 130, with lung surfactant increasing greatly, in response, by about day 135,[48] and although lamb fetal cortisol is mostly of maternal origin during the first 122 days, 88% or more is of fetal origin by day 136 of gestation.[49] Although the timing of fetal cortisol concentration elevation in sheep may vary somewhat, it averages about 11.8 days before the onset of labor.[50] In several livestock species (e.g. cattle, sheep, goats, and pigs), the surge of fetal cortisol late in gestation triggers the onset of parturition by removing the progesterone block of cervical dilation and myometrial contraction. The mechanisms yielding this effect on progesterone differ among species. In the sheep, where progesterone sufficient for maintaining pregnancy is produced by the placenta after about day 70 of gestation,[51] [52] the prepartum fetal cortisol surge induces placental enzymatic conversion of progesterone to estrogen. (The elevated level of estrogen stimulates prostaglandin secretion and oxytocin receptor development.)

Exposure of fetuses to cortisol during gestation can have a variety of developmental outcomes, including alterations in prenatal and postnatal growth patterns. In marmosets, a species of New World primates, pregnant females have varying levels of cortisol during gestation, both within and between females. Infants born to mothers with high gestational cortisol during the first trimester of pregnancy had lower rates of growth in body mass indices than infants born to mothers with low gestational cortisol (about 20% lower). However, postnatal growth rates in these high-cortisol infants were more rapid than low-cortisol infants later in postnatal periods, and complete catch-up in growth had occurred by 540 days of age. These results suggest that gestational exposure to cortisol in fetuses has important potential fetal programming effects on both pre and postnatal growth in primates.[53]

Cortisol face

See also: Moon face. Increased cortisol levels may lead to facial swelling and bloating, creating a round and puffy appearance, referred to as "cortisol face."[54] [55] [56]

Synthesis and release

Cortisol is produced in the human body by the adrenal gland's zona fasciculata, the second of three layers comprising the adrenal cortex.[1] This cortex forms the outer "bark" of each adrenal gland, situated atop the kidneys. The release of cortisol is controlled by the hypothalamus of a brain. Secretion of corticotropin-releasing hormone by the hypothalamus triggers cells in its neighboring anterior pituitary to secrete adrenocorticotropic hormone (ACTH) into the vascular system, through which blood carries it to the adrenal cortex.[1] ACTH stimulates the synthesis of cortisol and other glucocorticoids, mineralocorticoid aldosterone, and dehydroepiandrosterone.[1]

Testing of individuals

Normal values indicated in the following tables pertain to humans (normal levels vary among species). Measured cortisol levels, and therefore reference ranges, depend on the sample type, analytical method used, and factors such as age and sex. Test results should, therefore, always be interpreted using the reference range from the laboratory that produced the result.[57] [58] [59] An individual's cortisol levels can be detected in blood, serum, urine, saliva, and sweat.[60]

Using the molecular weight of 362.460 g/mole, the conversion factor from μg/dL to nmol/L is approximately 27.6;[64] [65] thus, 10 μg/dL is about 276 nmol/L.

Reference ranges for urinalysis of free cortisol (urinary free cortisol or UFC)
Lower limit Upper limit Unit
28[66] or 30[67] 280 or 490 nmol/24h
10 or 11[68] 100 or 176 μg/24 h

Cortisol follows a circadian rhythm, and to accurately measure cortisol levels is best to test four times per day through saliva. An individual may have normal total cortisol but have a lower than normal level during a certain period of the day and a higher than normal level during a different period. Therefore, some scholars question the clinical utility of cortisol measurement.[69] [70] [71] [72]

Cortisol is lipophilic, and is transported bound to transcortin (also known as corticosteroid-binding globulin (CBG)) and albumin, while only a small part of the total serum cortisol is unbound and has biological activity.[73] This binding of cortisol to transcortin is accomplished through hydrophobic interactions in which cortisol binds in a 1:1 ratio.[74] Serum cortisol assays measures total cortisol, and its results may be misleading for patients with altered serum protein concentrations. The salivary cortisol test avoids this problem because only free cortisol can pass through the blood-saliva barrier.[75] [76] [77] [78] Transcortin particles are too large to pass through this barrier,[79] that consists of epithelial cell layers of the oral mucosa and salivary glands.[80]

Cortisol may be incorporated into hair from blood, sweat, and sebum. A 3 centimeter segment of scalp hair can represent 3 months of hair growth, although growth rates can vary in different regions of the scalp. Cortisol in hair is a reliable indicator of chronic cortisol exposure.[81]

Automated immunoassays lack specificity and show significant cross-reactivity due to interactions with structural analogs of cortisol, and show differences between assays. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can improve specificity and sensitivity.[82]

Disorders of cortisol production

Some medical disorders are related to abnormal cortisol production, such as:

Regulation

The primary control of cortisol is the pituitary gland peptide, ACTH, which probably controls cortisol by controlling the movement of calcium into the cortisol-secreting target cells.[86] ACTH is in turn controlled by the hypothalamic peptide corticotropin-releasing hormone (CRH), which is under nervous control. CRH acts synergistically with arginine vasopressin, angiotensin II, and epinephrine.[87] (In swine, which do not produce arginine vasopressin, lysine vasopressin acts synergistically with CRH.[88])

When activated macrophages start to secrete IL-1, which synergistically with CRH increases ACTH, T-cells also secrete glucosteroid response modifying factor (GRMF), as well as IL-1; both increase the amount of cortisol required to inhibit almost all the immune cells.[89] Immune cells then assume their own regulation, but at a higher cortisol setpoint. The increase in cortisol in diarrheic calves is minimal over healthy calves, however, and falls over time.[90] The cells do not lose all their fight-or-flight override because of interleukin-1's synergism with CRH. Cortisol even has a negative feedback effect on interleukin-1—especially useful to treat diseases that force the hypothalamus to secrete too much CRH, such as those caused by endotoxic bacteria. The suppressor immune cells are not affected by GRMF, so the immune cells' effective setpoint may be even higher than the setpoint for physiological processes. GRMF affects primarily the liver (rather than the kidneys) for some physiological processes.[91]

High-potassium media (which stimulates aldosterone secretion in vitro) also stimulate cortisol secretion from the fasciculata zone of canine adrenals[92] [93] — unlike corticosterone, upon which potassium has no effect.[94]

Potassium loading also increases ACTH and cortisol in humans.[95] This is probably the reason why potassium deficiency causes cortisol to decline (as mentioned) and causes a decrease in conversion of 11-deoxycortisol to cortisol.[96] This may also have a role in rheumatoid-arthritis pain; cell potassium is always low in RA.[97]

Ascorbic acid presence, particularly in high doses has also been shown to mediate response to psychological stress and speed the decrease of the levels of circulating cortisol in the body post-stress. This can be evidenced through a decrease in systolic and diastolic blood pressures and decreased salivary cortisol levels after treatment with ascorbic acid.[98]

Factors increasing cortisol levels

Biochemistry

Biosynthesis

Cortisol is synthesized from cholesterol. Synthesis takes place in the zona fasciculata of an adrenal cortex.[105] [106] [107]

The name "cortisol" is derived from the word 'cortex'. Cortex means "the outer layer"—a reference to the adrenal cortex, the part of the adrenal gland where cortisol is produced.[108]

While the adrenal cortex in humans also produces aldosterone in the zona glomerulosa and some sex hormones in the zona reticularis, cortisol is its main secretion in humans and several other species.[106] In cattle, corticosterone levels may approach[109] or exceed cortisol levels.[110] [111] In humans, the medulla of the adrenal gland lies under its cortex, mainly secreting the catecholamines adrenaline (epinephrine) and noradrenaline (norepinephrine) under sympathetic stimulation.[112]

Synthesis of cortisol in the adrenal gland is stimulated by the anterior lobe of the pituitary gland with ACTH; ACTH production is, in turn, stimulated by CRH, which is released by the hypothalamus. ACTH increases the concentration of cholesterol in the inner mitochondrial membrane, via regulation of the steroidogenic acute regulatory protein. It also stimulates the main rate-limiting step in cortisol synthesis, in which cholesterol is converted to pregnenolone and catalyzed by Cytochrome P450SCC (side-chain cleavage enzyme).[113]

Metabolism

11beta-hydroxysteroid dehydrogenases

Cortisol is metabolized reversibly to cortisone[114] by the 11-beta hydroxysteroid dehydrogenase system (11-beta HSD), which consists of two enzymes: 11-beta HSD1 and 11-beta HSD2. The metabolism of cortisol to cortisone involves oxidation of the hydroxyl group at the 11-beta position.[115]

Overall, the net effect is that 11-beta HSD1 serves to increase the local concentrations of biologically active cortisol in a given tissue; 11-beta HSD2 serves to decrease local concentrations of biologically active cortisol. If hexose-6-phosphate dehydrogenase (H6PDH) is present, the equilibrium can favor the activity of 11-beta HSD1. H6PDH regenerates NADPH, which increases the activity of 11-beta HSD1, and decreases the activity of 11-beta HSD2.[116]

An alteration in 11-beta HSD1 has been suggested to play a role in the pathogenesis of obesity, hypertension, and insulin resistance known as metabolic syndrome.[117]

An alteration in 11-beta HSD2 has been implicated in essential hypertension and is known to lead to the syndrome of apparent mineralocorticoid excess (SAME).

A-ring reductases (5alpha- and 5beta-reductases)

Cortisol is also metabolized irreversibly into 5-alpha tetrahydrocortisol (5-alpha THF) and 5-beta tetrahydrocortisol (5-beta THF), reactions for which 5-alpha reductase and 5-beta-reductase are the rate-limiting factors, respectively. 5-Beta reductase is also the rate-limiting factor in the conversion of cortisone to tetrahydrocortisone.

Cytochrome P450, family 3, subfamily A monooxygenases

Cortisol is also metabolized irreversibly into 6β-hydroxycortisol by cytochrome p450-3A monooxygenases, mainly, CYP3A4.[118] [119] [114] [120] Drugs that induce CYP3A4 may accelerate cortisol clearance.[121]

Chemistry

Cortisol is a naturally occurring pregnane corticosteroid and is also known as 11β,17α,21-trihydroxypregn-4-ene-3,20-dione.

Animals

In animals, cortisol is often used as an indicator of stress and can be measured in blood,[122] saliva, urine,[123] hair,[124] and faeces.[125]

See also

External links

Notes and References

  1. Lightman SL, Birnie MT, Conway-Campbell BL . Dynamics of ACTH and Cortisol Secretion and Implications for Disease . Endocrine Reviews . 41 . 3 . June 2020 . 32060528 . 7240781 . 10.1210/endrev/bnaa002 .
  2. Taves MD, Gomez-Sanchez CE, Soma KK . Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function . American Journal of Physiology. Endocrinology and Metabolism . 301 . 1 . E11-24 . July 2011 . 21540450 . 3275156 . 10.1152/ajpendo.00100.2011 .
  3. Book: Hoehn K, Marieb EN . Human Anatomy & Physiology . Benjamin Cummings . San Francisco . 2010 . 978-0-321-60261-9 . Anatomy .
  4. Chyun YS, Kream BE, Raisz LG . Cortisol decreases bone formation by inhibiting periosteal cell proliferation . Endocrinology . 114 . 2 . 477–80 . February 1984 . 6690287 . 10.1210/endo-114-2-477 .
  5. DeRijk RH, Schaaf M, de Kloet ER . Glucocorticoid receptor variants: clinical implications . The Journal of Steroid Biochemistry and Molecular Biology . 81 . 2 . 103–122 . June 2002 . 12137800 . 10.1016/S0960-0760(02)00062-6 . 24650907 .
  6. Khani S, Tayek JA . Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome . Clin Sci (Lond) . 101 . 6 . 739–47 . December 2001 . 11724664 . 10.1042/cs1010739 . 2 February 2024 . 11 March 2024 . https://web.archive.org/web/20240311202019/https://portlandpress.com/clinsci/article-abstract/101/6/739/67449/Cortisol-increases-gluconeogenesis-in-humans-its?redirectedFrom=PDF . live .
  7. Book: Integrated endocrinology. Laycock JF . 2013. Wiley-Blackwell. Meeran, Karim.. 978-1-118-45064-2. Chichester, West Sussex, UK. 794973804.
  8. Coderre L, Srivastava AK, Chiasson JL . Role of glucocorticoid in the regulation of glycogen metabolism in skeletal muscle . The American Journal of Physiology . 260 . 6 Pt 1 . E927–32 . June 1991 . 1905485 . 10.1152/ajpendo.1991.260.6.E927.
  9. Macfarlane DP, Forbes S, Walker BR . Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome . en-US. The Journal of Endocrinology . 197 . 2 . 189–204 . May 2008 . 18434349 . 10.1677/JOE-08-0054 . free .
  10. Book: Kuo T, McQueen A, Chen TC, Wang JC . Glucocorticoid Signaling . Regulation of Glucose Homeostasis by Glucocorticoids . 872 . 99–126 . 2015 . 26215992 . 6185996 . 10.1007/978-1-4939-2895-8_5 . 978-1-4939-2895-8 . Advances in Experimental Medicine and Biology . Wang JC, Harris C. Springer .
  11. Sluiter JK, Frings-Dresen MH, Meijman TF, van der Beek AJ . Reactivity and recovery from different types of work measured by catecholamines and cortisol: a systematic literature overview . Occup Environ Med . 57 . 5 . 298–315 . May 2000 . 10769296 . 1739955 . 10.1136/oem.57.5.298 .
  12. Simmons PS, Miles JM, Gerich JE, Haymond MW . Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range . The Journal of Clinical Investigation . 73 . 2. 412–20 . February 1984 . 6365973 . 425032 . 10.1172/JCI111227 .
  13. Djurhuus CB, Gravholt CH, Nielsen S, Mengel A, Christiansen JS, Schmitz OE, Møller N. 2609285. July 2002. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. American Journal of Physiology. Endocrinology and Metabolism. 283. 1. E172–7. 10.1152/ajpendo.00544.2001. 12067858.
  14. Elenkov IJ . Glucocorticoids and the Th1/Th2 balance . Annals of the New York Academy of Sciences . 1024 . 1 . 138–46 . June 2004 . 15265778 . 10.1196/annals.1321.010 . 2004NYASA1024..138E . 9575617 . 11 September 2018 . 11 December 2022 . https://web.archive.org/web/20221211215505/https://zenodo.org/record/1235876 . live .
  15. Palacios R, Sugawara I . Hydrocortisone abrogates proliferation of T cells in autologous mixed lymphocyte reaction by rendering the interleukin-2 Producer T cells unresponsive to interleukin-1 and unable to synthesize the T-cell growth factor . Scandinavian Journal of Immunology . 15 . 1 . 25–31 . January 1982 . 6461917 . 10.1111/j.1365-3083.1982.tb00618.x . 41292936 .
  16. Book: Besedovsky HO, Del Rey A, Sorkin E . Integration of Activated Immune Cell Products in Immune Endocrine Feedback Circuits . Oppenheim JJ, Jacobs DM . Leukocytes and Host Defense . Progress in Leukocyte Biology . 5 . Alan R. Liss . New York . 1986 . 200 .
  17. Book: Demers Lawrence M . Adrenal Cortical Disorders . Burtis Carl A, Ashwood Edward R, Bruns David E, Sawyer, Barbara G. Tietz Fundamentals of Clinical Chemistry . Saunders El Sevier . St. Louis, Missouri . 2008 . 749–765 .
  18. Book: Murphy, Kenneth. The Humoral Immune Response . Janeway's Immunobiology, 8th ed.. Garland Science Taylor & Francis Group . New York,NY . 2012 . 387 .
  19. Mavoungou E, Bouyou-Akotet MK, Kremsner PG . Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30) . Clinical and Experimental Immunology . 139 . 2 . 287–96 . February 2005 . 15654827 . 1809301 . 10.1111/j.1365-2249.2004.02686.x .
  20. Book: Flohe L, Beckman R, Giertz H, Loschen G . Oxygen Centered Free Radicals as Mediators of Inflammation . Sies H . Oxidative stress . Orlando . London . 1985 . 405 . 978-0-12-642760-8 .
  21. 10.1002/cncr.31943 . The impact of psychosocial stress and stress management on immune responses in patients with cancer . 2019 . Antoni . Michael H. . Dhabhar . Firdaus S. . Cancer . 125 . 9 . 1417–1431 . 30768779 . 6467795 .
  22. Wheatland R . Molecular mimicry of ACTH in SARS – implications for corticosteroid treatment and prophylaxis . Med Hypotheses . 63 . 5 . 855–862 . May 2004 . 15488660 . 7126000 . 10.1016/j.mehy.2004.04.009 .
  23. Akbas EM, Akbas N . COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency . Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub . 165 . 1 . 1–7 . March 2021 . 33542545 . 10.5507/bp.2021.011 . free .
  24. Buford TW, Willoughby DS . Impact of DHEA(S) and cortisol on immune function in aging: a brief review . Appl Physiol Nutr Metab . 33 . 3 . 429–33 . June 2008 . 18461094 . 10.1139/H08-013 .
  25. Schernthaner-Reiter MH, Wolf P, Vila G, Luger A . The Interaction of Insulin and Pituitary Hormone Syndromes . Front Endocrinol (Lausanne) . 12 . 626427 . 2021 . 33995272 . 8113952 . 10.3389/fendo.2021.626427 . free .
  26. Book: King MB . Lange Q & A . McGraw-Hill, Medical Pub. Division . New York . 2005 . 978-0-07-144578-8 . registration .
  27. Book: Baynes J, Dominiczak M . Medical biochemistry . Mosby Elsevier . 2009 . 978-0-323-05371-6 .
  28. Deutsch E . [Pathogenesis of thrombocytopenia. 2. Distribution disorders, pseudo-thrombocytopenias] . de. Fortschritte der Medizin . 96 . 14 . 761–2 . April 1978 . 346457 .
  29. Kucharz EJ . Hormonal control of collagen metabolism. Part II . Endocrinologie . 26 . 4 . 229–37 . 1988 . 3062759 .
  30. Encyclopedia: Manchester, KL . Allison, NH . Munro JB. 1964 . Sites of Hormonal Regulation of Protein Metabolism . Mammalian Protein Metabolism . Academic Press . New York . 229? 273?.
  31. Husband AJ, Brandon MR, Lascelles AK . The effect of corticosteroid on absorption and endogenous production of immunoglobulins in calves . The Australian Journal of Experimental Biology and Medical Science . 51 . 5 . 707–10 . October 1973 . 4207041 . 10.1038/icb.1973.67 .
  32. Posey WC, Nelson HS, Branch B, Pearlman DS . The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels . The Journal of Allergy and Clinical Immunology . 62 . 6 . 340–8 . December 1978 . 712020 . 10.1016/0091-6749(78)90134-3 .
  33. Li X, Xiang X, Hu J, Goswami R, Yang S, Zhang A, Wang Y, Li Q, Bi X . Association Between Serum Cortisol and Chronic Kidney Disease in Patients with Essential Hypertension . Kidney Blood Press Res . 41 . 4 . 384–91 . 2016 . 27344357 . 10.1159/000443435 . 8633049 . free .
  34. Hill KJ, Lumbers ER, Elbourne I . The actions of cortisol on fetal renal function . J Dev Physiol . 10 . 1 . 85–96 . February 1988 . 3351211 .
  35. Biber J, Murer H, Mohebbi N, Wagner CA . Renal Handling of Phosphate and Sulfate . Compr Physiol . 4 . 2 . 771–92 . April 2014 . 24715567 . 10.1002/cphy.c120031 . 9780470650714 . 16 September 2023 . 1 November 2023 . https://web.archive.org/web/20231101095038/https://www.zora.uzh.ch/id/eprint/95625/1/Renal_handling_of_phosphate_and.pdf . live .
  36. Book: Kure DW, Pollock RE, Weichselbaum RR, Bast RC, Ganglier TS, Holland JF, Frei E . Holland-Frei Cancer Medicine . 2003 . Decker . Hamilton, Ontario . 978-1-55009-213-4 . 6th . McKay LI, Cidlowski JA . Physiologic and Pharmacologic Effects of Corticosteroids . https://www.ncbi.nlm.nih.gov/books/NBK13780/ . registration .
  37. Sandle GI, Keir MJ, Record CO . The effect of hydrocortisone on the transport of water, sodium, and glucose in the jejunum. Perfusion studies in normal subjects and patients with coeliac disease . Scandinavian Journal of Gastroenterology . 16 . 5 . 667–71 . 1981 . 7323700 . 10.3109/00365528109182028 .
  38. Mason PA, Fraser R, Morton JJ, Semple PF, Wilson A . The effect of sodium deprivation and of angiotensin II infusion on the peripheral plasma concentrations of 18-hydroxycorticosterone, aldosterone and other corticosteroids in man . Journal of Steroid Biochemistry . 8 . 8 . 799–804 . August 1977 . 592808 . 10.1016/0022-4731(77)90086-3 .
  39. Book: Gorbman A, Dickhoff WW, Vigna SR, Clark NB, Muller AF . Comparative endocrinology . Wiley . New York . 1983 . 978-0-471-06266-0 .
  40. Book: Muller AF, Oconnor CM . An International Symposium on Aldosterone . Little Brown & Co . 1958 . 58 .
  41. Knight RP, Kornfeld DS, Glaser GH, Bondy PK . Effects of intravenous hydrocortisone on electrolytes of serum and urine in man . The Journal of Clinical Endocrinology and Metabolism . 15 . 2 . 176–81 . February 1955 . 13233328 . 10.1210/jcem-15-2-176 .
  42. Book: The Human Adrenal Gland . registration . Lea & Febiger . Soffer LJ, Dorfman RI, Gabrilove JL . 1961 . Philadelphia.
  43. Kokoshchuk GI, Pakhmurnyĭ BA . Role of glucocorticoids in regulating the acid-excreting function of the kidneys . Fiziologicheskii Zhurnal SSSR imeni I. M. Sechenova . 65 . 5 . 751–4 . May 1979 . 110627 .
  44. Web site: Kennedy R . Cortisol (Hydrocortisone) . The Doctors' Medical Library . 14 June 2013 . https://web.archive.org/web/20130703071625/http://www.medical-library.net/content/view/1401/41 . 3 July 2013 . dead .
  45. McAuley MT, Kenny RA, Kirkwood TB, Wilkinson DJ, Jones JJ, Miller VM . A mathematical model of aging-related and cortisol induced hippocampal dysfunction . BMC Neuroscience . 10 . 26 . March 2009 . 19320982 . 2680862 . 10.1186/1471-2202-10-26 . free .
  46. Book: Martin PA, Crump MH . The adrenal gland . Dooley MP, Pineda MH . McDonald's veterinary endocrinology and reproduction . 5th . Iowa State Press . Ames, Iowa . 2003 . 978-0-8138-1106-2 .
  47. Book: Lundberg U . Neuroendocrine Measures . Contrada R, Baum A . The Handbook of Stress Science: Biology, Psychology, and Health . New York . Springer Publishing Company . 2010 . 351 . 978-0-8261-1771-7 . 12 March 2020 . [...] epinephrine, norepinephrine, and cortisol are considered the most important 'stress hormones,' although a number of other hormones are also influenced by stress [...]. . 11 March 2024 . https://web.archive.org/web/20240311202051/https://books.google.com/books?id=EXVlk8pnEKIC . live .
  48. Mescher EJ, Platzker AC, Ballard PL, Kitterman JA, Clements JA, Tooley WH . Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb . Journal of Applied Physiology . 39 . 6 . 1017–21 . December 1975 . 2573 . 10.1152/jappl.1975.39.6.1017.
  49. Hennessy DP, Coghlan JP, Hardy KJ, Scoggins BA, Wintour EM . The origin of cortisol in the blood of fetal sheep . The Journal of Endocrinology . 95 . 1 . 71–9 . October 1982 . 7130892 . 10.1677/joe.0.0950071 .
  50. Magyar DM, Fridshal D, Elsner CW, Glatz T, Eliot J, Klein AH, Lowe KC, Buster JE, Nathanielsz PW . Time-trend analysis of plasma cortisol concentrations in the fetal sheep in relation to parturition . Endocrinology . 107 . 1 . 155–9 . July 1980 . 7379742 . 10.1210/endo-107-1-155 .
  51. Ricketts AP, Flint AP . Onset of synthesis of progesterone by ovine placenta . The Journal of Endocrinology . 86 . 2 . 337–47 . August 1980 . 6933207 . 10.1677/joe.0.0860337 .
  52. Al-Gubory KH, Solari A, Mirman B . Effects of luteectomy on the maintenance of pregnancy, circulating progesterone concentrations and lambing performance in sheep . Reproduction, Fertility, and Development . 11 . 6 . 317–22 . 1999 . 10972299 . 10.1071/RD99079 .
  53. Mustoe AC, Birnie AK, Korgan AC, Santo JB, French JA . Natural variation in gestational cortisol is associated with patterns of growth in marmoset monkeys (Callithrix geoffroyi) . General and Comparative Endocrinology . 175 . 3 . 519–26 . February 2012 . 22212825 . 3268124 . 10.1016/j.ygcen.2011.12.020 .
  54. News: What is cortisol? How to lower levels amid concerns over "cortisol face" - CBS News . 11 August 2024 . www.cbsnews.com . 8 August 2024.
  55. News: What Is Cortisol Face? — and Can Stress Really Change Your Appearance? . 11 August 2024 . Peoplemag . en.
  56. News: Marshall . Mallika . What is the trending TikTok topic "cortisol face" and what causes it? - CBS Boston . 11 August 2024 . www.cbsnews.com . 31 July 2024.
  57. Bianchi L, Campi B, Sessa MR, De Marco G, Ferrarini E, Zucchi R, Marcocci C, Vitti P, Manetti L, Saba A, Agretti P . Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method . J Endocrinol Invest . 42 . 11 . 1299–1305 . November 2019 . 31012054 . 10.1007/s40618-019-01050-5 . 128361547 .
  58. Panton KK, Mikkelsen G, Irgens WØ, Hovde AK, Killingmo MW, Øien MA, Thorsby PM, Åsberg A . New reference intervals for cortisol, cortisol binding globulin and free cortisol index in women using ethinyl estradiol . Scand J Clin Lab Invest . 79 . 5 . 314–319 . September 2019 . 31161807 . 10.1080/00365513.2019.1622031 . 174806302 . free . 11250/2739760 . free .
  59. Pai J, Joshi RK, Bhaskar S, Patil S, Bv S, R S, Iyengar AR, Agarwal N, Shorie M . Revisiting the cortisol reference ranges in humans: the role of demographics . Endocrine . 82 . 2 . 414–418 . November 2023 . 37501014 . 10.1007/s12020-023-03456-x . 260246830 . 2 February 2024 . 3 December 2023 . https://web.archive.org/web/20231203012804/https://www.researchsquare.com/article/rs-2840050/latest.pdf . live .
  60. Yeasmin . Sanjida . Ullah . Ahasan . Wu . Bo . Zhang . Xueqiao . Cheng . Li-Jing . Enzyme-Mimics for Sensitive and Selective Steroid Metabolite Detection . ACS Applied Materials & Interfaces . 2023 . 15 . 11 . 10.1021/acsami.2c21980 . 36908226 . 257494057 . 8 April 2023 . subscription . 8 April 2023 . https://web.archive.org/web/20230408234418/https://pubs.acs.org/doi/10.1021/acsami.2c21980 . live .
  61. https://web.archive.org/web/20100720014644/http://www.goodhope.org.uk/Departments/pathweb/refranges.htm Biochemistry Reference Ranges at Good Hope Hospital
  62. Rotman-Pikielny P, Rouach V, Chen O, Gur HG, Limor R, Stern N . Serum cortisol levels in patients admitted to the department of medicine: Prognostic correlations and effects of age, infection, and comorbidity . Am J Med Sci . 332 . 2 . 61–67 . August 2006 . 16909051 . 10.1097/00000441-200608000-00002 . 5004535 .
  63. Derived from molar values using molar mass of 362 g/mol
  64. Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P, Mosconi C, Balacchi C, Golfieri R, Cosentino ER, Borghi C, Vicennati V, Pasquali R, Pagotto U . The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk . J Clin Endocrinol Metab . 104 . 11 . 5519–5528 . November 2019 . 31381072 . 10.1210/jc.2019-00365 . 199437371 . free .
  65. Scott SM, Watterberg KL . Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants . Pediatr Res . 37 . 1 . 112–6 . January 1995 . 7700725 . 10.1203/00006450-199501000-00021 . 21870513 . free .
  66. Converted from μg/24h, using molar mass of 362.460 g/mol
  67. Görges R, Knappe G, Gerl H, Ventz M, Stahl F . Diagnosis of Cushing's syndrome: re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group . . 22 . 4 . 241–9 . April 1999 . 10342356 . 10.1007/bf03343551 . 1239611 .
  68. Converted from nmol/24h, using molar mass of 362.460 g/mol
  69. Izawa S, Sugaya N, Ogawa N, Shirotsuki K, Nomura S . A validation study on fingernail cortisol: correlations with one-month cortisol levels estimated by hair and saliva samples . Stress . 24. 6. 734–741 . April 2021 . 33792492 . 10.1080/10253890.2021.1895113 . 232481968 . free .
  70. Turpeinen U, Hämäläinen E . Determination of cortisol in serum, saliva and urine . Best Practice & Research. Clinical Endocrinology & Metabolism . 27 . 6 . 795–801 . December 2013 . 24275191 . 10.1016/j.beem.2013.10.008 .
  71. Dolomie-Fagour L, Corcuff JB . [Is free plasmatic cortisol measurement useful in intensive care unit?] . fr. Annales de Biologie Clinique . 66 . 1 . 31–41 . 2008 . 18227002 . 10.1684/abc.2008.0189 . 31 January 2024 .
  72. Maidana P, Bruno OD, Mesch V . [A critical analysis of cortisol measurements: an update] . es. Medicina . 73 . 6 . 579–84 . 2013 . 24356273 .
  73. Verbeeten KC, Ahmet AH . The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency . Journal of Pediatric Endocrinology & Metabolism . 31 . 2 . 107–115 . January 2018 . 29194043 . 10.1515/jpem-2017-0270 . 28588420 . free .
  74. Henley D, Lightman S, Carrell R . Cortisol and CBG - Getting cortisol to the right place at the right time . Pharmacology & Therapeutics . 166 . 128–135 . October 2016 . 27411675 . 10.1016/j.pharmthera.2016.06.020 . 1983/d7ed507d-52d5-496b-ae1f-de220ae1b190 . 8 March 2023 . 20 August 2023 . https://web.archive.org/web/20230820212304/https://research-information.bris.ac.uk/ws/files/183969438/CBG_Final_Henley_revised_submitted2.pdf . live .
  75. de Medeiros GF, Lafenêtre P, Janthakhin Y, Cerpa JC, Zhang CL, Mehta MM, Mortessagne P, Helbling JC, Ferreira G, Moisan MP . Corticosteroid-Binding Globulin Deficiency Specifically Impairs Contextual and Recognition Memory Consolidation in Male Mice . Neuroendocrinology . 109 . 4 . 322–332 . 2019 . 30904918 . 10.1159/000499827 . 85498121 .
  76. Henley DE, Lightman SL . New insights into corticosteroid-binding globulin and glucocorticoid delivery . Neuroscience . 180 . 1–8 . April 2011 . 21371536 . 10.1016/j.neuroscience.2011.02.053 . 26843500 .
  77. Salzano C, Saracino G, Cardillo G . Possible Adrenal Involvement in Long COVID Syndrome . Medicina (Kaunas) . 57 . 10 . October 2021 . 1087 . 34684123 . 8537520 . 10.3390/medicina57101087 . free .
  78. Granger DA, Hibel LC, Fortunato CK, Kapelewski CH . Medication effects on salivary cortisol: tactics and strategy to minimize impact in behavioral and developmental science . Psychoneuroendocrinology . 34 . 10 . 1437–48 . November 2009 . 19632788 . 10.1016/j.psyneuen.2009.06.017 . 3100315 .
  79. 10.1017/S0962728600030657 . Can non-invasive glucocorticoid measures be used as reliable indicators of stress in animals? . 2006 . Lane . J. . Animal Welfare . 15 . 4 . 331–342 . 80026053 .
  80. Lin GC, Smajlhodzic M, Bandian AM, Friedl HP, Leitgeb T, Oerter S, Stadler K, Giese U, Peham JR, Bingle L, Neuhaus W . An In Vitro Barrier Model of the Human Submandibular Salivary Gland Epithelium Based on a Single Cell Clone of Cell Line HTB-41: Establishment and Application for Biomarker Transport Studies . Biomedicines . 8 . 9 . August 2020 . 302 . 32842479 . 7555419 . 10.3390/biomedicines8090302 . free .
  81. Lee DY, Kim E, Choi MH . Technical and clinical aspects of cortisol as a biochemical marker of chronic stress . . 48 . 4 . 209–216 . 2015 . 10.5483/bmbrep.2015.48.4.275 . 4436856 . 25560699.
  82. El-Farhan N, Rees DA, Evans C . Measuring cortisol in serum, urine and saliva - are our assays good enough? . Annals of Clinical Biochemistry . 54 . 3 . 308–322 . May 2017 . 28068807 . 10.1177/0004563216687335 . 206397561 . free .
  83. Web site: Cushing's Syndrome. The Lecturio Medical Concept Library. 11 July 2021. 22 September 2021. https://web.archive.org/web/20210922231327/https://www.lecturio.com/concepts/cushings-syndrome/. live.
  84. Web site: Cushing's Syndrome. National Endocrine and Metabolic Diseases Information Service (NEMDIS). 16 March 2015. July 2008. These benign, or noncancerous, tumors of the pituitary gland secrete extra ACTH. Most people with the disorder have a single adenoma. This form of the syndrome, known as Cushing's disease. https://web.archive.org/web/20150210104139/http://endocrine.niddk.nih.gov/pubs/cushings/cushings.aspx#1. 10 February 2015. dead.
  85. Book: Forbis P . Stedman's medical eponyms . 2005 . Lippincott Williams & Wilkins . Baltimore, Md. . 978-0-7817-5443-9 . 167 . 2nd . 30 August 2017 . 24 February 2024 . https://web.archive.org/web/20240224160912/https://books.google.com/books?id=isqcnR6ryz0C&pg=PA167#v=onepage&q&f=false . live .
  86. Davies E, Kenyon CJ, Fraser R . The role of calcium ions in the mechanism of ACTH stimulation of cortisol synthesis . Steroids . 45 . 6 . 551–60 . June 1985 . 3012830 . 10.1016/0039-128X(85)90019-4 . 24454836 .
  87. Plotsky PM, Otto S, Sapolsky RM . Inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback . Endocrinology . 119 . 3 . 1126–30 . September 1986 . 3015567 . 10.1210/endo-119-3-1126 .
  88. Minton JE, Parsons KM . Adrenocorticotropic hormone and cortisol response to corticotropin-releasing factor and lysine vasopressin in pigs . Journal of Animal Science . 71 . 3 . 724–9 . March 1993 . 8385088 . 10.2527/1993.713724x.
  89. Fairchild SS, Shannon K, Kwan E, Mishell RI . T cell-derived glucosteroid response-modifying factor (GRMFT): a unique lymphokine made by normal T lymphocytes and a T cell hybridoma . Journal of Immunology . 132 . 2 . 821–7 . February 1984 . 10.4049/jimmunol.132.2.821 . 6228602 . 27300153 . free .
  90. Dvorak M . 1971 . Plasma 17-Hydroxycorticosteroid Levels in Healthy and Diarrheic Calves . British Veterinarian Journal . 127 . 372 .
  91. Stith RD, McCallum RE . General effect of endotoxin on glucocorticoid receptors in mammalian tissues . Circulatory Shock . 18 . 4 . 301–9 . 1986 . 3084123 .
  92. Mikosha AS, Pushkarov IS, Chelnakova IS, Remennikov GY . 1991 . Potassium Aided Regulation of Hormone Biosynthesis in Adrenals of Guinea Pigs Under Action of Dihydropyridines: Possible Mechanisms of Changes in Steroidogenesis Induced by 1,4, Dihydropyridines in Dispersed Adrenocorticytes . Fiziol. [Kiev] . 37 . 60 .
  93. Web site: Ameer Saadallah Al – Zacko. 11 July 2013. https://web.archive.org/web/20131111193718/http://medicinemosul.uomosul.edu.iq/files/pages/page_9904388.pdf. 11 November 2013. dead.
  94. Mendelsohn FA, Mackie C . 24873537 . Relation of intracellular K+ and steroidogenesis in isolated adrenal zona glomerulosa and fasciculata cells . Clinical Science and Molecular Medicine . 49 . 1 . 13–26 . July 1975 . 168026 . 10.1042/cs0490013.
  95. Ueda Y, Honda M, Tsuchiya M, Watanabe H, Izumi Y, Shiratsuchi T, Inoue T, Hatano M . Response of plasma ACTH and adrenocortical hormones to potassium loading in essential hypertension . Japanese Circulation Journal . 46 . 4 . 317–22 . April 1982 . 6283190 . 10.1253/jcj.46.317 . free .
  96. Bauman K, Muller J . 1972 . Effect of potassium on the final status of aldosterone biosynthesis in the rat. I 18-hydroxylation and 18hydroxy dehydrogenation. II beta-hydroxylation . Acta Endocrinol. . 69 . 4 . I 701–717, II 718–730 . 10.1530/acta.0.0690701. 5067076 .
  97. LaCelle PL, Morgan ES, Atwater EC . 1964 . An investigation of total body potassium in patients with rheumatoid arthritis . Proceedings of the Annual Meeting of the American Rheumatism Association, Arthritis and Rheumatism . 7 . 3 . 321 .
  98. Brody S, Preut R, Schommer K, Schürmeyer TH . A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress . Psychopharmacology . 159 . 3 . 319–24 . January 2002 . 11862365 . 10.1007/s00213-001-0929-6 . 2778669 .
  99. Silverman MN, Pearce BD, Biron CA, Miller AH . Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection . Viral Immunology . 18 . 1 . 41–78 . 2005 . 15802953 . 1224723 . 10.1089/vim.2005.18.41 .
  100. Robson PJ, Blannin AK, Walsh NP, Castell LM, Gleeson M . Effects of exercise intensity, duration and recovery on in vitro neutrophil function in male athletes . International Journal of Sports Medicine . 20 . 2 . 128–35 . February 1999 . 10190775 . 10.1055/s-2007-971106 . 2572545 .
  101. Fuqua JS, Rogol AD . Neuroendocrine alterations in the exercising human: implications for energy homeostasis . Metabolism . 62 . 7 . 911–21 . July 2013 . 23415825 . 10.1016/j.metabol.2013.01.016.
  102. Book: Smith JL, Gropper SA, Groff JL . Advanced nutrition and humanmetabolism . Wadsworth Cengage Learning . Belmont, CA . 2009 . 247 . 978-0-495-11657-8 .
  103. Whittaker J, Harris M . Low-carbohydrate diets and men's cortisol and testosterone: Systematic review and meta-analysis . Nutrition and Health . 543–554 . March 2022 . 28 . 4 . 35254136 . 10.1177/02601060221083079 . 9716400 . 247251547 .
  104. Stachowicz M, Lebiedzińska A . December 2016 . The effect of diet components on the level of cortisol . European Food Research and Technology . 242 . 12 . 2001–2009 . 10.1007/s00217-016-2772-3 . 88721472 . 1438-2385. free .
  105. Book: 10.1007/978-1-4419-1005-9_171. 978-1-4419-1005-9. Cortisol . Encyclopedia of Behavioral Medicine . 2013 . 507–512 . Stalder T, Kirschbaum C .
  106. 20 November 2021. 10.1186/s12917-021-03069-4. Changes in metabolic and hormonal profiles during transition period in dairy cattle – the role of spexin. free . BMC Veterinary Research . 17 . 1 . 359 . 34798894 . 8605515 . Mikuła R, Pruszyńska-Oszmałek E, Pszczola M, Rząsińska J, Sassek M, Nowak KW, Nogowski L, Kołodziejski PA .
  107. Payne AH, Hales DB . Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones . Endocr Rev . 25 . 6 . 947–70 . December 2004 . 15583024 . 10.1210/er.2003-0030.
  108. Web site: Cortisol Etymology of cortisol by etymonline . 23 April 2024 . 22 December 2022 . https://web.archive.org/web/20221222174911/https://www.etymonline.com/word/cortisol . live .
  109. Willett LB, Erb RE . Short term changes in plasma corticoids in dairy cattle . Journal of Animal Science . 34 . 1 . 103–11 . January 1972 . 5062063 . 10.2527/jas1972.341103x.
  110. Web site: Hypokalemia in Adult Cattle - Metabolic Disorders . 23 April 2024 . 9 December 2023 . https://web.archive.org/web/20231209143012/https://www.merckvetmanual.com/metabolic-disorders/disorders-of-potassium-metabolism/hypokalemia-in-adult-cattle . live .
  111. Web site: Corticosteroids in Animals - Pharmacology . 23 April 2024 . 20 April 2024 . https://web.archive.org/web/20240420163445/https://www.merckvetmanual.com/pharmacology/inflammation/corticosteroids-in-animals . live .
  112. Book: 19 January 2022. 978-3-030-84737-1 . Endocrine Surgery Comprehensive Board Exam Guide . Springer . Shifrin AL, Raffaelli M, Randolph GW, Gimm O .
  113. Book: Margioris AN, Tsatsanis C . Chrousos G . Adrenal physiology and diseases . 2011 . ACTH Action on the Adrenal . http://www.endotext.org/adrenal/adrenal5/adrenalframe5.htm . Endotext.org . 5 June 2012 . 29 November 2011 . https://web.archive.org/web/20111129102929/http://www.endotext.org/adrenal/adrenal5/adrenalframe5.htm . dead .
  114. Finken MJ, Andrews RC, Andrew R, Walker BR . Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases . The Journal of Clinical Endocrinology and Metabolism . 84 . 9 . 3316–3321 . September 1999 . 10487705 . 10.1210/jcem.84.9.6009 . free .
  115. Dammann C, Stapelfeld C, Maser E . Expression and activity of the cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 is tissue and species-specific . Chemico-Biological Interactions . 303 . 57–61 . April 2019 . 30796905 . 10.1016/j.cbi.2019.02.018 . 2019CBI...303...57D . 73467693 .
  116. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A . Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase . FEBS Letters . 571 . 1–3 . 129–133 . July 2004 . 15280030 . 10.1016/j.febslet.2004.06.065 . 6360244 . free . 2004FEBSL.571..129A .
  117. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM . 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response . Endocrine Reviews . 25 . 5 . 831–66 . October 2004 . 15466942 . 10.1210/er.2003-0031 . free .
  118. Web site: 6beta-Hydroxycortisol . 20 November 2021 . 20 November 2021 . https://web.archive.org/web/20211120230517/https://pubchem.ncbi.nlm.nih.gov/compound/6beta-Hydroxycortisol . live .
  119. Luceri F, Fattori S, Luceri C, Zorn M, Mannaioni P, Messeri G . Gas chromatography-mass spectrometry measurement of 6beta-OH-cortisol/cortisol ratio in human urine: a specific marker of enzymatic induction . Clin Chem Lab Med . 39 . 12 . 1234–9 . December 2001 . 11798083 . 10.1515/CCLM.2001.198. 12216877 .
  120. Huang FR, Zhou C, Zhang XY, Shen Y, Zhang HW, Wang YQ, Sun LN . Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies . Xenobiotica . 51 . 10 . 1199–1206 . October 2021 . 34402388 . 10.1080/00498254.2021.1969481. 237150260 .
  121. Aquinos BM, García Arabehety J, Canteros TM, de Miguel V, Scibona P, Fainstein-Day P . [Adrenal crisis associated with modafinil use] . es . Medicina (B Aires) . 81 . 5 . 846–849 . 2021 . 34633961.
  122. van Staaveren N, Teixeira DL, Hanlon A, Boyle LA . The effect of mixing entire male pigs prior to transport to slaughter on behaviour, welfare and carcass lesions . PLOS ONE . 10 . 4 . e0122841 . 2015 . 25830336 . 4382277 . 10.1371/journal.pone.0122841 . 2015PLoSO..1022841V . free .
  123. Schalke E, Stichnoth J, Ott S, Jones-Baade R . Clinical signs caused by the use of electric training collars on dogs in everyday life situations . Applied Animal Behaviour Science . 105 . 4 . 369–380 . 2007 . 10.1016/j.applanim.2006.11.002. 31552322 .
  124. Accorsi PA, Carloni E, Valsecchi P, Viggiani R, Gamberoni M, Tamanini C, Seren E . Cortisol determination in hair and faeces from domestic cats and dogs . General and Comparative Endocrinology . 155 . 2 . 398–402 . January 2008 . 17727851 . 10.1016/j.ygcen.2007.07.002 .
  125. Möstl E, Messmann S, Bagu E, Robia C, Palme R . Measurement of glucocorticoid metabolite concentrations in feces of domestic livestock . Zentralblatt für Veterinarmedizin. Reihe A . 46 . 10 . 621–631 . December 1999 . 10638300 . 10.1046/j.1439-0442.1999.00256.x .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Cortisol".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.